[go: up one dir, main page]

Ishizaki et al., 1997 - Google Patents

Prediction of changes in the clinical pharmacokinetics of basic drugs on the basis of octanol‐water partition coefficients

Ishizaki et al., 1997

Document ID
17863136133621908945
Author
Ishizaki J
Yokogawa K
Nakashima E
Ichimura F
Publication year
Publication venue
Journal of pharmacy and pharmacology

External Links

Snippet

A physiologically based pharmacokinetic model for basic drugs has been established on the basis of octanol‐water partition coefficients of the non‐ionized, unbound drugs (Poct). The parameters for the physiological model in man were estimated from a regression equation …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons

Similar Documents

Publication Publication Date Title
Matin et al. Pharmacokinetics of tolbutamide: prediction by concentration in saliva
Hinderling et al. Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans
Chen et al. Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers.
Blyden et al. Pharmacokinetics of diphenhydramine and a demethylated metabolite following intravenous and oral administration
Murray et al. Variable furosemide absorption and poor predictability of response in elderly patients
Holford et al. The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: concentration‐effect relationships.
Yokogawa et al. Relationships in the structure–tissue distribution of basic drugs in the rabbit
Kimelblatt et al. Dose and serum concentration relationships in cimetidine-associated mental confusion
KINNEY et al. The pharmacokinetics and pharmacology of oral diltiazem in normal volunteers
Ishizaki et al. Prediction of changes in the clinical pharmacokinetics of basic drugs on the basis of octanol‐water partition coefficients
Major et al. Isosorbide 5‐mononitrate kinetics
Rakhit et al. Pharmacokinetics of quinidine and three of its metabolites in man
Leighton et al. Colchicine clearance is impaired in alcoholic cirrhosis
Lima et al. Disopyramide pharmacokinetics and bioavailability following the simultaneous administration of disopyramide and14C-disopyramide
Foreman Individual variability in response to haloperidol
Fattinger et al. Population pharmacokinetics of quinidine.
Pan et al. Cocaine and alcohol interactions in the rat: effect on cocaine pharmacokinetics and pharmacodynamics
Ishizaki et al. Relationships between the hepatic intrinsic clearance or blood cell-plasma partition coefficient in the rabbit and the lipophilicity of basic drugs
Bird et al. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid
Yokagawa et al. Brain regional pharmacokinetics of biperiden in rats
Mason et al. Comparative plasma concentrations of quinidine following administration of one intramuscular and three oral formulations to 13 human subjects
Okuda et al. Determination of atropine in biological specimens by high-performance liquid chromatography
Wong et al. Plasma concentrations of propranolol and 4‐hydroxypropranolol during chronic oral propranolol therapy.
Silke et al. Pharmacokinetic and pharmacodynamic studies with prazosin in chronic heart failure
Brès et al. Pharmacokinetics of sulpiride in humans after intravenous and intramuscular administrations